Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Expert explains data submitted in support of Pfizer COVID-19 vaccine for kids

Date

Expert explains data submitted in support of Pfizer COVID-19 vaccine for kids



MARIA: PFIZER IS ASKING THE FDA TO GIVE EMERGENCY USE AUTHORIZATION TO ITS VACCINE FOR YOUNGER CHILDREN. HERE TO ANSWER YOUR QUESTIONS IS DR. TODD ELLERIN, CHIEF OF INFECTIOUS DISEASES AT SOUTH SHORE HEAL. ED: SO LET’S GO THROUGH WHAT WE KNOW. IT’S FORID KS AGE 5 TO 11. AND LIKE THE VACCINE FOR PEOPLE 12 AND OLDER, IT’S TWO DOSES GIVEN 21 DAYS APART, BUT EACH DOSE IS SMALLER. ABOUT ONE-THIRD OF THE ADULT VACCINE. NOW, WHAT CAN YOU TELL US ABOUT EFFICA?CY >> YOU SUMMARIZED IT PERFECTLY. THIS STUDY WHIT ABOUT 2300 KIDS REALLY WASN’T DESIGNED AS AN EFFECTIVENESS TRIAL. WILL YOU NEED MUCH LARGER TRIAL. IT SHOWS THATHE T IMMUNE RESPONSE IN THESE KIDS WERE EXCELLENT. IT WAS VERY SAFE. THE FEELING IS IF ETH KIDS HAVE AN IMMUNE RESPONSE LIKE OLDER KIDS WHICH THEY DID OR YOUNG ADULTS, IT SULHO BE EFFECTI.VE MARIA: PFIZER RELEASED SOME DETAILS LAST MONTH IN A PRESS RELEASE, SO I KNOW YOU’RE STILL WAITING TO SEE THE DATA, BUTRE A WE LEARNING ANYTHING ABOUT SIDE EFFECTS? // >> THE SIDE EFFECTS IN THIS 5 TO 11 GROUPS WAS SIMILAR TO OLDER KIDS. NOT CHMU DIFFERENT. SIDE EFFECTS YOU EXPECT. LOW GDE FEVERINGS, ACHINESS, HEADACHE AND FATUEIG. ED: VACCINE EXPERTS FOR THE FDA WILL MEET OCTOBER 26 TO DISCUSS PFIZER’S APPLICATION. DO YOU THINK THREE WEEKS IS ENOUGH TIME TO REVIEW THE TADA >> THIS FDA COMMITTEE, THIS ADVISORY COMMITTEE IS VERY GOOD. AT AISS YES, I DO. REMEMBER, FOR THE ADULT VACCINE TRAIL THERE WERE 40,000 SUBJECTS. THEY’RE LOOKING AT PROBABLY 2300 AND 3000 KIDS. THEY’LL BE ABLE TO TURN IT AROUND. THE KNOW THE GOAL WAS HALLOWEEN AND HOPEFULLY IT WILL BE AUTHORIZED BEFORE THEN. REMEMBER, NO CHILD WILLE H IMMUNITY BY HALLOWEEN. ED: ODGO CLARITY. MARIA: YOU TOLD U BEFORE, YOUNG CHILDREN HAVE A MUCH LOWER RISK OF SERIOUS SIDE EFFECTS OR DEATH FROM COVID. SO IF THIS VCIACNE IS APPROVED, DO YOU THINK IT’S GOING TO BE DIFFICULT TO PERSUADE PARENTS TO GET IT FOR THEIRID K >> OF COURSE, THERE WILL BE SOME REPANTS IT WILL BE DIFFICULT. ONE THIRD OF PARENTS ARE AREN’ INTERESTED. IF YOU’RE VACCINE HESITANT PARENT, IT MAY DBEIFFICULT TO GIVE THE GREEN LIGHT. IT IS IMPORTANT, SO FAR 500 CHILDREN HAVE DIED OF COVID.U KNOW ABOUT THAT MYSTERIOUS INFLAMMATORY INDREAM THAT N BE LIFE-THREATENING. OVER 8 MILLION CHILDREN OVERHE T AGE OF 12, ABOUT 15 HAVE RECEIVED THIS VACCINE. IT LOOKS VERY SAFE. THE OTHER POINT, PEDIATRICIANS WILL PLAY AEY K ROLE. ONE THING, I WANT TO DEDICATE THIS SESSION TO A PATIENT OF MINE THAT JUST DIED. HE WAS YOUNGER THAN ME, YOUNGER THAN 50. HE WAS UNVACCINATED. HE ACTUALLY LOST BHOTIS H PARENTS TO COVID MONTH BEFORE. THEY WERE BOTH UNVACCINATED. HE ACTUALLY SAID TO ME BEFORE HE WAS T INTUBATED. HE WANTED TO BE A VOICE TORY T TO CONVINCESE THO WHO UNVACCINATED TO GET THE VACCINE. I WANT TO SHARE HIS VOICE AND WHATE H WOULDAY S TODAY IF HE COULD TALK TO YOU. ED: THANK YOU FOR SHANGRI THAT. THAT’S A POWERFUL MESSAGE

Advertisement

Expert explains data submitted in support of Pfizer COVID-19 vaccine for kids

“The immune response in these kids was excellent and it was very safe,” Dr. Todd Ellerin, director of infectious diseases at South Shore Health, said about the Pfizer

“The immune response in these kids was excellent and it was very safe,” Dr. Todd Ellerin, director of infectious diseases at South Shore Health, said about the Pfizer

Advertisement

Facebook
Twitter
Reddit
LinkedIn
Email

More
articles

Join DBN Today!

Let DBN help guide you to success!

Doctors Business Network offers everything new and existing health care providers need to establish and build a successful career! Sign up with DBN today and let us help you succeed!

DBN Health News